All Journals

Advances the scientific understanding, prevention, and treatment of mental disorders, publishing rigorous original work across clinical psychiatry, biological and neuropsychiatry, psychopharmacology, and mental health services research that informs both bench investigators and frontline clinicians. The journal welcomes original research, systematic reviews, meta-analyses, case reports, and editorials on mood and anxiety disorders, depression, post-traumatic stress disorder, obsessive-compulsive disorder, autism spectrum and neurodevelopmental conditions, addiction and substance use disorders, forensic psychiatry, and the social determinants of mental health, including stigma and discrimination. Emerging therapeutics such as psychedelic-assisted psychotherapy and novel psychopharmacological agents are within scope. We value methodological transparency across epidemiological, clinical-trial, translational, and qualitative designs, and encourage studies addressing under-served populations and global mental health. Every submission undergoes double-blind peer review. Accepted articles are published open access under a Creative Commons Attribution (CC-BY 4.0) licence with authors retaining copyright, receive a permanent Crossref DOI, and are made discoverable through OpenAlex, Google Scholar, and an OAI-PMH endpoint. The journal follows COPE ethical principles.

Dedicated to advancing the surgical and translational science of the brain, spine, and peripheral nervous system. The journal serves an international community of neurosurgeons, neurointerventionalists, spine surgeons, neuro-oncologists, residents, and clinical researchers seeking a trusted, globally accessible venue for high-quality neurosurgical scholarship. The journal's core focus spans cerebrovascular and endovascular neurosurgery, including intracranial aneurysm treatment, endovascular aneurysm repair, stent-assisted coiling, flow-diverter therapy, and subarachnoid hemorrhage management. We equally welcome work in spine and spinal neurosurgery, neurotrauma and decompressive craniectomy, neurosurgical oncology and CNS pathology, skull base surgery, functional neurosurgery, and the bioethical and outcomes dimensions of neurosurgical practice. We publish original research, systematic and narrative reviews, case reports, technical notes, audits, and editorials addressing clinical, methodological, and translational questions. Every submission undergoes rigorous double-blind peer review; accepted articles are published open access under a Creative Commons Attribution (CC-BY 4.0) licence with authors retaining copyright, and each article receives a permanent Crossref DOI. Articles are discoverable through Google Scholar and OpenAlex and harvestable via our OAI-PMH endpoint, and the journal follows COPE ethical principles to safeguard research integrity, citability, and the long-term preservation of the neurosurgical record.

Advancing the science and clinical practice of feeding and eating disorders. The scope spans anorexia nervosa, bulimia nervosa, binge eating disorder, ARFID, and other specified feeding or eating disorders. We welcome work on epidemiology, screening and diagnosis, body image and psychosocial determinants, the metabolic correlates of disordered eating (leptin, ghrelin, PCOS, insulin resistance), comorbidity with depression and anxiety, and treatments including cognitive behavioral therapy and family-based treatment. Article types include original research, systematic and narrative reviews, clinical case reports, study protocols, and editorials, each evaluated by double-blind peer review. Accepted articles publish open access under a CC-BY 4.0 licence with authors retaining copyright, receive a permanent Crossref DOI, and are discoverable via OpenAlex, Google Scholar, and an OAI-PMH endpoint. Editorial practice follows COPE principles, with an article-processing charge on acceptance and waivers available.

Dedicated to the science and practice of psychological medicine at the interface of mind, brain, and body. As an open access psychiatry journal, it advances rigorous scholarship across clinical psychiatry, psychosomatic and consultation-liaison medicine, neuropsychiatry, and behavioral medicine, connecting clinicians, researchers, and trainees worldwide. The journal publishes original research, systematic reviews, clinical guidelines, case reports, and editorials spanning mood, anxiety and stress-related disorders (including depression, PTSD, and emotional distress in caregivers), cognitive impairment and dementia (with cognitive screening tools such as the MMSE and MoCA), substance-related and addictive disorders, sleep and circadian disturbance, and the psychological dimensions of medical illness. Methodological breadth is welcomed, from epidemiology, actigraphy, and neuropsychological assessment to translational and qualitative studies. JOPM serves psychiatrists, psychologists, neuroscientists, primary-care physicians, and allied mental-health professionals seeking trustworthy, internationally accessible evidence. Every submission undergoes double-blind peer review. Accepted articles are published open access under a Creative Commons Attribution (CC-BY 4.0) licence with authors retaining copyright, assigned a permanent Crossref DOI, indexed for discovery via OpenAlex and Google Scholar, and exposed through an OAI-PMH endpoint. The journal follows COPE ethical principles.

Disseminates rigorous original research, reviews, case reports, and case series across the full spectrum of clinical and translational neurology, with particular depth in cerebrovascular disease and stroke, epilepsy and neuroinflammation, peripheral neuropathy and neuropathic pain, neurotrauma and sports neurology, and neuro-otology and vestibular disorders. The journal serves neurologists, neurosurgeons, clinical researchers, neurophysiologists, and trainees, and actively welcomes work from underserved and global settings, including stroke epidemiology and outcomes research from sub-Saharan Africa and other low-resource regions. Methodological emphasis spans prospective and multicentre cohort studies, case-control designs, electrodiagnosis and neurophysiology, and mechanistic and systematic reviews. Every submission undergoes double-blind peer review. Accepted articles are published open access under a Creative Commons Attribution (CC-BY 4.0) licence with authors retaining copyright, and each receives a permanent Crossref DOI ensuring citability, discoverability through OpenAlex and Google Scholar, and harvesting via the journal's OAI-PMH endpoint. Editorial practice follows COPE principles, with article-processing charges applied on acceptance and waivers or discounts available.

Dedicated to the science, diagnosis, treatment, and care of Alzheimer's disease and related neurodegenerative disorders. As a dedicated Alzheimer's disease journal, it serves neurologists, geriatricians, neuroscientists, neuropsychologists, gerontologists, and care researchers seeking a rigorous, internationally discoverable venue for original scholarship on dementia and cognitive decline. The journal welcomes work across the full translational spectrum: amyloid-beta and tau biomarkers, neuroimaging, mild cognitive impairment, Lewy body dementia, vascular and frontotemporal dementia, and Parkinson's disease and parkinsonism. We particularly encourage studies on neuroprotection, non-pharmacological and e-health interventions, assistive technologies, activities of daily living, and quality of life and well-being for patients and caregivers. We publish original research, systematic and narrative reviews, clinical case reports, methodological papers, and editorials. Every submission undergoes double-blind peer review; accepted articles appear open access under a Creative Commons Attribution (CC-BY 4.0) licence with authors retaining copyright. Each article receives a permanent Crossref DOI and is discoverable through OpenAlex, Google Scholar, and our OAI-PMH endpoint. The journal follows COPE ethical principles, and article-processing charges apply on acceptance with waivers and discounts available.

Dedicated to the science and clinical care of affective (mood) disorders. The journal welcomes original research, reviews, and case reports across the full mood spectrum, including major depressive disorder, persistent depressive disorder, bipolar I and II disorders, and anxiety and stress-related conditions, with particular interest in comorbidity, suicidality, and self-harm. We publish work spanning clinical psychiatry, psychopharmacology, psychotherapy and behavioural interventions, neuromodulation, and digital mental health, alongside affective neuroscience, neuroimaging, genetics, neuroinflammation, and biomarker discovery. Epidemiological, translational, perinatal, paediatric, and geriatric studies are equally encouraged, as is research addressing the global burden and social determinants of mood disorders. The journal serves psychiatrists, clinical psychologists, neuroscientists, primary-care clinicians, and public mental-health researchers seeking a rigorous, internationally accessible venue for their findings. Every submission undergoes rigorous double-blind peer review. Accepted articles are published under a Creative Commons Attribution (CC-BY 4.0) licence with authors retaining copyright, assigned a permanent Crossref DOI, and made discoverable through OpenAlex, Google Scholar, and an OAI-PMH endpoint. The journal follows COPE ethical principles, with article-processing charges due on acceptance and waivers and discounts available.

Examines how the nervous system gives rise to behavior. The journal publishes original research, reviews, case reports, and methodological papers spanning neural circuits of behavior, learning and memory, neuropharmacology, neuroethology, and the behavioral consequences of neurological and psychiatric disorders. Our remit bridges molecular, systems, and behavioral levels of analysis in both animal models and human populations. We welcome work using contemporary tools and paradigms, including in vivo electrophysiology, optogenetics, the open field and other behavioral assays, neuromuscular electrical stimulation, and machine learning approaches to behavioral phenotyping. Representative topics include neuroprotection in models of Parkinson's disease, neuroglial dysregulation in autism spectrum disorder, the neural basis of social behavior, and translational strategies that move behavioral neuroscience toward clinical application. The journal serves neuroscientists, behavioral and comparative psychologists, neuropharmacologists, and translational and clinical researchers seeking a rigorous, internationally accessible venue. Every accepted manuscript undergoes double-blind peer review. All articles are published open access under a Creative Commons Attribution (CC-BY 4.0) license with authors retaining copyright, receive a permanent Crossref DOI, and are made discoverable through OpenAlex, Google Scholar, and an OAI-PMH endpoint. Editorial practice follows COPE principles.